November
Dr. Daniel Hardy, PhD’03 has won the 2022 Dr. Joseph Gilbert Research Contribution of the Year Award for his team’s study published in Scientific Reports, which examined the effects of THC, the psychoactive component of cannabis, and its potential long-term impact in fetal development in pre-clinical models.
Dr. Robert Langer, Doctor of Science’14 sat on the Pharma, Biotech, and MedTech Awards Committee for the Prix Galien Awards 2022.
Dr. Saman Maleki, PhD’14 will present on "Microbiome modification with fecal microbiota transplant from healthy donors before anti-PD1 therapy reduces primary resistance to immunotherapy in advanced and metastatic melanoma patient" at The Society for Immunotherapy of Cancer's 37th Annual Meeting.
Isobel Scarisbrick's, MSc’87. research shows that halting an enzyme can slow multiple sclerosis in mice. The research model is based on the theory that infection with viral infection early in life results in an eventual abnormal immune response in the brain and spinal cord.
Leanne Taylor, BMSc’14, was featured in The Healthcare Technology's Report's 2022 Top 25 Women Leaders in Biotechnology.
Tango Therapeutics announced the appointment of Dr. Ron Weitzman, MD’90., F.A.C.P. as Chief Medical Officer.
